Kiora Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Kiora Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Kiora Pharmaceuticals Inc
Rating: 2.00833325
Author: Trendlyne DVM scores

about

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, ...

2.12 -0.09 (-4.07%)

49.28% Fall from 52W High

73,386

XNAS Volume

High volume today

XNAS 23 Jan, 2026 4:30 PM (EST)

Not Eligible

Mid Valuation

32.3 / 100

Technically Neutral

48.0 / 100

1Yr Price target upside is 466%

1 analysts

Kiora Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Kiora Pharma Inc Live Stock Price Today, Share Analysis and Chart

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, ...

49.28% Fall from 52W High

High volume today

SWOT Analysis

Kiora Pharma Inc Live Price Chart